Cargando…
Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
Autor principal: | Sheth, Jay U |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186630/ https://www.ncbi.nlm.nih.gov/pubmed/33913890 http://dx.doi.org/10.4103/ijo.IJO_671_21 |
Ejemplares similares
-
Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021) -
Commentary: Deep learning in retinopathy of prematurity: Where do we stand?
por: Sen, Parveen, et al.
Publicado: (2022) -
Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020) -
Commentary: Viral serology testing before cataract surgery: Where do we stand?
por: Nayak, Bhagabat, et al.
Publicado: (2022) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005)